Bio-Rad Laboratories, Inc. BIO.B Life Science — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GoodwillGross.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s life science — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s life science — goodwill?
- Bio-Rad Laboratories, Inc. (BIO.B) reported life science — goodwill of $490.5M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s life science — goodwill changed year-over-year?
- Bio-Rad Laboratories, Inc.'s life science — goodwill increased by 47.2% year-over-year, from $333.3M to $490.5M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s life science — goodwill?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s life science — goodwill has grown at a 11.7% compound annual growth rate (CAGR), from $1.17B to $1.81B.
- What does life science — goodwill mean?
- The total value of intangible assets like brand reputation and synergies recorded from acquisitions within the Life Science segment.
- How do you interpret life science — goodwill?
- An increase suggests recent acquisitions, while a decrease may indicate impairment or divestitures.
- How does life science — goodwill compare across companies?
- Standard across life science and diagnostics peers that utilize M&A as a growth strategy.